Molecular and Histopathologic Characteristics of Radioiodine-Refractory Papillary Thyroid Cancer

被引:0
|
作者
Choi, Sung-eun
Pyo, Ju Yeon
Kim, Ji-seop
Shin, Eunah
Hong, Soon W.
机构
[1] Gangnam Severance Hosp, Seoul, South Korea
[2] Hanyang Univ, Guri Hosp, Guri Si, Kyeonggi Do, South Korea
[3] CHA Gangnam Hosp, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
576
引用
收藏
页码:147A / 148A
页数:2
相关论文
共 50 条
  • [1] Molecular and Histopathologic Characteristics of Radioiodine-Refractory Papillary Thyroid Cancer
    Choi, Sung-eun
    Pyo, Ju Yeon
    Kim, Ji-seop
    Shin, Eunah
    Hong, Soon Won
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 147A - 148A
  • [2] TERT mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancer
    Pyo, Ju Yeon
    Cha, Yoon Jin
    Hong, Soon Won
    [J]. JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2024,
  • [3] Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer
    Krajewska, Jolanta
    Jarzab, Barbara
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (12): : 1331 - 1340
  • [4] Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
    Ovcaricek, Petra Petranovic
    Campenni, Alfredo
    de Keizer, Bart
    Deandreis, Desiree
    Kreissl, Michael C.
    Vrachimis, Alexis
    Tuncel, Murat
    Giovanella, Luca
    [J]. CANCERS, 2023, 15 (17)
  • [5] Radioiodine-refractory thyroid cancer: a complex challenge
    Vitale, Giovanni
    Pellegrino, Giuseppe
    Desiderio, Elio
    Barrea, Luigi
    [J]. MINERVA MEDICA, 2021, 112 (06) : 686 - 688
  • [6] Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance
    Shen, Huize
    Zhu, Rui
    Liu, Yanyang
    Hong, Yangjian
    Ge, Jiaming
    Xuan, Jie
    Niu, Wenyuan
    Yu, Xuefei
    Qin, Jiang-Jiang
    Li, Qinglin
    [J]. DRUG RESISTANCE UPDATES, 2024, 72
  • [7] Cabozantinib for radioiodine-refractory differentiated thyroid cancer
    Chiapponi, Costanza
    Hartmann, Milan J. M.
    Hescheler, Daniel A.
    Alakus, Hakan
    [J]. ONKOLOGE, 2021, 27 (12): : 1241 - 1242
  • [8] Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology
    Samimi, Hilda
    Haghpanah, Vahid
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020, 31 (09): : 627 - 630
  • [9] Lenvatinib in Radioiodine-Refractory Thyroid Cancer REPLY
    Schlumberger, Martin
    Tahara, Makoto
    Wirth, Lori J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19): : 1868 - 1868
  • [10] Advanced Radioiodine-refractory differentiated Thyroid Cancer
    Spitzweg, Christine
    Auernhammer, Christoph J.
    Geisler, Julia
    Boeck, Stefan
    Heinemann, Volker
    Bartenstein, Peter
    Goeke, Burkhard
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (03) : 168 - 171